step 6 semaglutide Once-weekly 7·2 mg in adults with obesity (STEP UP): a randomised, controlled, phase 3b trial Semaglutide 2.4-mg Injection as a

Weight loss during week one is typically 0-2 pounds

Choosing the wrong ones can worsen nausea, accelerate muscle loss, and stall your progress

Administered through weekly injections, Ozempic offers a comprehensive approach to managing type 2 diabetes by providing the following benefits: Facilitating insulin secretion: This ensures proper glucose absorption during digestion and helps maintain stable blood sugar levels

Get it right and every dose becomes predictable, accurate, and effective

Proven Weight Loss: Clinical studies, including the SURMOUNT-1 trial, have shown that Mounjaro can help people with obesity (without diabetes) lose an average of 15% to over 20% of their body weight

It also increases the level of nerve growth factor, which supports the growth and survival of neurons